Page 46 - Forward Looking Statement News Today

ENGLEWOOD, CO, November 22, 2021  – Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent inflammatory conditions, today announced that Mike Macaluso is taking a one-year medical leave of absence from his role as Chairman and CEO, effective immediat

Download as PDF November 22, 2021 8:05am EST DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--( )-- IMV Inc.

Cronos Group Inc. is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 Management Cease Trade Orders and disclosing receipt of a Nasdaq Listing delinquency letter. On November 9, 2021, the Company announced that it applied for a management cease trade order with the applicable securities regulatory authorities in Canada on the basis that the ...

Heating Up Cancer Immunotherapy November 2021 Forward Looking Statement Certain statements in this... | November 3, 2021

Cronos Group unveils its new CBG product, the SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy, made using fermentation and proprietary methods to produce CBG...

Cronos Group Inc.  is pleased to announce the launch of its SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy, the first cannabis edible of its kind in Canada to feature THC and cultured cannabigerol from fermentation in a sweet, delicious gummy for adult consumers. As the only cannabis gummy in Canada to feature cultured CBG, one of many rare cannabinoids found in small quantities within the cannabis plant, this ...

/PRNewswire/ -- Galileo Life Sciences Inc (OTC: MDRM), also known as Modern Mobility Aids, (The Company) is a Nevada-based company, whose strategic focus lies...

/PRNewswire/ -- Galileo Life Sciences Inc (OTC: MDRM), also known as Modern Mobility Aids, (The Company) is a Nevada-based company, whose strategic focus lies...

In addition, the company also provides update on the ongoing GTB-3550 Phase 1 trial in relapsed/refractory AML and MDS

WALTHAM, Mass., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in...